Evidence map›Paper›PMID 34903738›Full record

ArticleNature communications2021

Nuclear pore protein NUP210 depletion suppresses metastasis through heterochromatin-mediated disruption of tumor cell mechanical response.

Ruhul Amin, Anjali Shukla, Jacqueline Jufen Zhu, Sohyoung Kim, Ping Wang, Simon Zhongyuan Tian, Andy D Tran, Debasish Paul, Steven D Cappell, Sandra Burkett and 8 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 57 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Stress transmission towards the nucleus of the cell.Frontiers in cell and developmental biology · 2026
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 3 institutions in 1 country.

Ruhul AminLaboratory of Cancer Biology and Genetics, National Cancer Institute, NIH, Bethesda, MD, USA. ruhul.amin@nih.gov.ORCID http://orcid.org/0000-0001-8826-4040
Anjali ShuklaLaboratory of Cancer Biology and Genetics, National Cancer Institute, NIH, Bethesda, MD, USA.
Jacqueline Jufen ZhuThe Jackson Laboratory for Genomic Medicine, Farmington, CT, USA.ORCID http://orcid.org/0000-0001-6416-4563
Sohyoung KimLaboratory of Receptor Biology and Gene Expression, National Cancer Institute, NIH, Bethesda, MD, USA.ORCID http://orcid.org/0000-0002-6140-7918
Ping WangThe Jackson Laboratory for Genomic Medicine, Farmington, CT, USA.
Simon Zhongyuan TianThe Jackson Laboratory for Genomic Medicine, Farmington, CT, USA.
Andy D TranLaboratory of Cancer Biology and Genetics, National Cancer Institute, NIH, Bethesda, MD, USA.ORCID http://orcid.org/0000-0002-2388-7121
Debasish PaulLaboratory of Cancer Biology and Genetics, National Cancer Institute, NIH, Bethesda, MD, USA.
Steven D CappellLaboratory of Cancer Biology and Genetics, National Cancer Institute, NIH, Bethesda, MD, USA.ORCID http://orcid.org/0000-0002-2885-7327
Sandra BurkettMolecular Cytogenetics Core Facility, National Cancer Institute, NIH, Frederick, MD, USA.ORCID http://orcid.org/0000-0002-5476-4028
Huaitian LiuLaboratory of Cancer Biology and Genetics, National Cancer Institute, NIH, Bethesda, MD, USA.
Maxwell P LeeLaboratory of Cancer Biology and Genetics, National Cancer Institute, NIH, Bethesda, MD, USA.ORCID http://orcid.org/0000-0003-3738-1292
Michael J KruhlakLaboratory of Cancer Biology and Genetics, National Cancer Institute, NIH, Bethesda, MD, USA.
Jennifer E DwyerMolecular Pathology Unit, Laboratory of Cancer Biology and Genetics, National Cancer Institute, NIH, Bethesda, MD, USA.
R Mark SimpsonMolecular Pathology Unit, Laboratory of Cancer Biology and Genetics, National Cancer Institute, NIH, Bethesda, MD, USA.
Gordon L HagerLaboratory of Receptor Biology and Gene Expression, National Cancer Institute, NIH, Bethesda, MD, USA.ORCID http://orcid.org/0000-0002-9300-5331
Yijun RuanThe Jackson Laboratory for Genomic Medicine, Farmington, CT, USA.
Kent W HunterLaboratory of Cancer Biology and Genetics, National Cancer Institute, NIH, Bethesda, MD, USA. hunterk@mail.nih.gov.ORCID http://orcid.org/0000-0001-5963-8808
National Cancer Institute · USJackson Laboratory · USNational Institutes of Health · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mechanical signals from the extracellular microenvironment have been implicated in tumor and metastatic progression. Here, we identify nucleoporin NUP210 as a metastasis susceptibility gene for human estrogen receptor positive (ER+) breast cancer and a cellular mechanosensor. Nup210 depletion suppresses lung metastasis in mouse models of breast cancer. Mechanistically, NUP210 interacts with LINC complex protein SUN2 which connects the nucleus to the cytoskeleton. In addition, the NUP210/SUN2 complex interacts with chromatin via the short isoform of BRD4 and histone H3.1/H3.2 at the nuclear periphery. In Nup210 knockout cells, mechanosensitive genes accumulate H3K27me3 heterochromatin modification, mediated by the polycomb repressive complex 2 and differentially reposition within the nucleus. Transcriptional repression in Nup210 knockout cells results in defective mechanotransduction and focal adhesion necessary for their metastatic capacity. Our study provides an important role of nuclear pore protein in cellular mechanosensation and metastasis.

Indexed as

AnimalsBreast NeoplasmsBromodomain Containing ProteinsCCCTC-Binding FactorCell Line, TumorCell MovementCytoskeletonEnhancer of Zeste Homolog 2 ProteinFocal AdhesionsGene Expression Regulation, NeoplasticHeterochromatinHistonesHumansMechanotransduction, CellularMethyltransferasesMiceBrd4 protein, mouseBromodomain Containing ProteinsCCCTC-Binding FactorCtcf protein, mouseEnhancer of Zeste Homolog 2 ProteinEzh2 protein, mouseHeterochromatinHistonesMethyltransferasesNuclear Pore Complex ProteinsNuclear ProteinsNup210 protein, mouseRepressor ProteinsSuv39h1 protein, mouseTranscription Factors

Identifiers

PMID34903738
PMCPMC8669001
OpenAlexW4200224518

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.